September 3, 2019
Shionogi said on September 2 that a higher rate of resistance to Xofluza (baloxavir marboxil) was observed in younger pediatric patients, according to its analysis of completed clinical studies for the novel flu medicine. PA/I38X-substituted viruses with reduced susceptibility to...read more